Dexmethylphenidate Extended-Release Capsules in Children with Attention-Deficit/Hyperactivity Disorder

A study to compare the release of 20mg of dexmethylphenidate extended-release capsules against placebo spread over a period of 12 hours in children afflicted with attention-deficit/hyperactivity disorder (ADHD) is conducted. Findings reveal that dexmethylphenidate provided significant improvement.

Saved in:
Bibliographic Details
Published inJournal of the American Academy of Child and Adolescent Psychiatry Vol. 47; no. 2; pp. 199 - 208
Main Authors Silva, Raul R, Muniz, Rafael, Pestreich, Linda, Brams, Matthew, Mao, Alice R, Childress, Ann, Wang, James
Format Journal Article
LanguageEnglish
Published United States Lippincott Williams & Wilkins 01.02.2008
Subjects
Attention Deficit Disorder with Hyperactivity - drug therapy
Attention Deficit Disorders
Central Nervous System Stimulants - administration & dosage
Central Nervous System Stimulants - adverse effects
Central Nervous System Stimulants - therapeutic use
Child
Children
Cross-Over Studies
Delayed-Action Preparations
Dexmethylphenidate Hydrochloride
Double-Blind Method
Drug Administration Schedule
Drug Therapy
Female
Humans
Hyperactivity
Male
Methylphenidate - administration & dosage
Methylphenidate - adverse effects
Methylphenidate - analogs & derivatives
Personality Assessment
Social Environment
Stereoisomerism
Treatment Outcome
Online AccessGet more information

Cover

More Information
Summary:A study to compare the release of 20mg of dexmethylphenidate extended-release capsules against placebo spread over a period of 12 hours in children afflicted with attention-deficit/hyperactivity disorder (ADHD) is conducted. Findings reveal that dexmethylphenidate provided significant improvement.
ISSN:0890-8567
DOI:10.1097/chi.0b013e31815cd9a4